POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PMR patients: steroid-free remission with rituximab?
Disease control CompletedThis study tested whether rituximab, a drug that calms the immune system, can help people with polymyalgia rheumatica (PMR) stop taking steroids sooner. PMR causes pain and stiffness, and steroids are the main treatment but have side effects. 114 adults with newly diagnosed PMR t…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New IV treatment for inflammatory conditions shows early promise
Disease control CompletedThis study tested an intravenous (IV) form of secukinumab in 65 adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). The goal was to see how the drug moves through the body and whether it is safe. Participants received multiple doses, and researchers monitored …
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug combo could reduce steroid use in painful rheumatic condition
Disease control CompletedThis study tested two doses of secukinumab (a drug that calms the immune system) combined with a steroid taper in 381 adults aged 50+ with polymyalgia rheumatica (PMR), a condition causing severe muscle pain and stiffness. The goal was to see if secukinumab helps patients achieve…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:39 UTC